Generic vs. brand: are these seizure meds equal?
NCT ID NCT07393022
First seen Feb 06, 2026 · Last updated May 23, 2026 · Updated 16 times
Summary
This study tested whether a new granule form of levetiracetam works the same as the standard tablet in 20 healthy adults. Participants took a single dose of each version under fasting conditions. The goal was to check bioequivalence, meaning the body absorbs and processes both forms similarly. Results help confirm that the granule form is a reliable alternative for people who need this seizure medication.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEALTH ADULT SUBJECTS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Biopharma Services Inc.
Toronto, Ontario, Canada
Conditions
Explore the condition pages connected to this study.